Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging
Christian Schmidkonz, Simon Rauber, Armin Atzinger, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 11, pp. 1485-1491
Closed Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

The Latest Developments in Imaging of Fibroblast Activation Protein
Annette Altmann, Uwe Haberkorn, Jens T. Siveke
Journal of Nuclear Medicine (2020) Vol. 62, Iss. 2, pp. 160-167
Open Access | Times Cited: 193
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients
Frederik L. Giesel, Clemens Kratochwil, Joel Schlittenhardt, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 13, pp. 4377-4385
Open Access | Times Cited: 153
State-of-the-art of FAPI-PET imaging: a systematic review and meta-analysis
Martina Sollini, Margarita Kirienko, Fabrizia Gelardi, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 13, pp. 4396-4414
Open Access | Times Cited: 122
Fibroblast activation protein-based theranostics in cancer research: A state-of-the-art review
Liang Zhao, Jianhao Chen, Yizhen Pang, et al.
Theranostics (2022) Vol. 12, Iss. 4, pp. 1557-1569
Open Access | Times Cited: 112
FAP and FAPI-PET/CT in Malignant and Non-Malignant Diseases: A Perfect Symbiosis?
Katharina Dendl, Stefan A. Koerber, Clemens Kratochwil, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4946-4946
Open Access | Times Cited: 102
Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
Mengting Li, Muhsin H. Younis, Yongxue Zhang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 8, pp. 2844-2868
Open Access | Times Cited: 74
FAPI PET/CT Imaging—An Updated Review
Kunal Ramesh Chandekar, Arun Prashanth, Sobhan Vinjamuri, et al.
Diagnostics (2023) Vol. 13, Iss. 12, pp. 2018-2018
Open Access | Times Cited: 38
CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis
Simon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 682-692
Open Access | Times Cited: 13
Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis
Yue Zhou, Xin Yang, Huipan Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 11, pp. 3493-3501
Open Access | Times Cited: 81
68Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the 68Ga-FAPI PET Prospective Observational Trial
Lukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Journal of Nuclear Medicine (2021) Vol. 63, Iss. 1, pp. 89-95
Open Access | Times Cited: 79
Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
Lukas Kessler, Justin Ferdinandus, Nader Hirmas, et al.
Journal of Nuclear Medicine (2021) Vol. 63, Iss. 6, pp. 890-896
Open Access | Times Cited: 76
The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG
Lianjun Lan, Hanxiang Liu, Ying‐Wei Wang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 3, pp. 963-979
Open Access | Times Cited: 75
Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer
Yizhen Pang, Long Zhao, Qihang Shang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 49, Iss. 4, pp. 1322-1337
Closed Access | Times Cited: 73
Clinical utility of [68Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma
Liang Zhao, Yizhen Pang, Hua Zheng, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 11, pp. 3606-3617
Closed Access | Times Cited: 66
FAPI-PET/CT in Cancer Imaging: A Potential Novel Molecule of the Century
Rong Huang, Yu Pu, Shun Huang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 62
Fibroblast Activation Protein Activates Macrophages and Promotes Parenchymal Liver Inflammation and Fibrosis
Aiting Yang, Yong-Ook Kim, Xuzhen Yan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2022) Vol. 15, Iss. 4, pp. 841-867
Open Access | Times Cited: 57
Non-oncologic incidental uptake on FAPI PET/CT imaging
Masatoshi Hotta, Angela C. Rieger, Mahbod G Jafarvand, et al.
British Journal of Radiology (2022) Vol. 96, Iss. 1142
Open Access | Times Cited: 55
Evaluation of Intestinal Fibrosis with 68Ga-FAPI PET/MR Enterography in Crohn Disease
Martina Scharitzer, Andrea Macher-Beer, Thomas Mang, et al.
Radiology (2023) Vol. 307, Iss. 3
Closed Access | Times Cited: 29
An updated review of the immunological mechanisms of keloid scars
Chih-Chun Lee, Chia-Hsuan Tsai, Chih‐Hao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Fibrotic phenotype of IgG4-related disease
Marco Lanzillotta, Emma Culver, Amita Sharma, et al.
The Lancet Rheumatology (2024) Vol. 6, Iss. 7, pp. e469-e480
Closed Access | Times Cited: 9
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
Manuel Röhrich, Juan José Rosales, Jorge Hoppner, et al.
Lara D. Veeken (2024) Vol. 63, Iss. 9, pp. 2473-2483
Closed Access | Times Cited: 7
Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity – initial experience and comparison to [18F]FDG PET/CT and MRI
Christian Linz, Roman C. Brands, Olivia Kertels, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 12, pp. 3951-3960
Open Access | Times Cited: 45
Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy
Daphne N. Dorst, Mark Rijpkema, Mijke Buitinga, et al.
Lara D. Veeken (2021) Vol. 61, Iss. 7, pp. 2999-3009
Open Access | Times Cited: 45
Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas
Xiao Zhang, Wenyu Song, Chunxia Qin, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 8, pp. 2635-2641
Closed Access | Times Cited: 43
Imaging Inflammation with Positron Emission Tomography
Janette Iking, Magdalena Staniszewska, Lukas Kessler, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 212-212
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top